Akari Therapeutics Plc (AKTX) has 5 open-market insider trades by 2 insiders since 2015. The most active filer is Abizer Gaslightwala, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Mark S. Cohen | Dir | — | 1 | $201K | 2015-09-18 |
| Abizer Gaslightwala | CEO | — | 4 | $57K | 2026-10-14 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Abizer Gaslightwala | CEO | Buy | $20K | 2025-08-21 |
| Abizer Gaslightwala | President | Buy | $7K | 2025-06-23 |
| Abizer Gaslightwala | President | Buy | $12K | 2025-06-20 |
| Abizer Gaslightwala | President | Buy | $18K | 2025-06-17 |
| Mark S. Cohen | Director | Buy | $201K | 2015-09-18 |
Companies that share insiders with AKTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.